Quantbot Technologies LP boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 81.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,774 shares of the company’s stock after acquiring an additional 12,457 shares during the quarter. Quantbot Technologies LP’s holdings in Cardinal Health were worth $1,858,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Kwmg LLC increased its stake in Cardinal Health by 9.7% during the third quarter. Kwmg LLC now owns 22,389 shares of the company’s stock worth $1,498,000 after acquiring an additional 1,971 shares during the last quarter. Allen Investment Management LLC boosted its holdings in shares of Cardinal Health by 77.5% in the third quarter. Allen Investment Management LLC now owns 52,999 shares of the company’s stock valued at $3,547,000 after purchasing an additional 23,137 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Cardinal Health by 10.8% in the third quarter. Bank of New York Mellon Corp now owns 3,846,209 shares of the company’s stock valued at $257,388,000 after purchasing an additional 375,742 shares during the period. DekaBank Deutsche Girozentrale boosted its holdings in shares of Cardinal Health by 41.5% in the third quarter. DekaBank Deutsche Girozentrale now owns 434,173 shares of the company’s stock valued at $28,742,000 after purchasing an additional 127,324 shares during the period. Finally, Sigma Planning Corp purchased a new stake in Cardinal Health during the third quarter worth $515,000. 88.64% of the stock is currently owned by institutional investors.

Cardinal Health, Inc. (NYSE:CAH) traded up $0.09 during midday trading on Friday, hitting $57.51. The company had a trading volume of 3,494,686 shares, compared to its average volume of 2,370,989. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06. Cardinal Health, Inc. has a 52-week low of $55.69 and a 52-week high of $84.88. The firm has a market cap of $18,140.00, a P/E ratio of 10.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.88.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $33.48 billion. During the same period in the prior year, the firm earned $1.24 EPS. The firm’s revenue was up 1.9% on a year-over-year basis. sell-side analysts predict that Cardinal Health, Inc. will post 4.97 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be given a $0.4624 dividend. This represents a $1.85 annualized dividend and a dividend yield of 3.22%. The ex-dividend date of this dividend is Friday, December 29th. Cardinal Health’s payout ratio is 53.94%.

CAH has been the subject of a number of analyst reports. BidaskClub lowered Cardinal Health from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 16th. Mizuho set a $70.00 target price on Cardinal Health and gave the stock a “hold” rating in a report on Tuesday, October 24th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Jefferies Group LLC set a $77.00 target price on Cardinal Health and gave the stock a “hold” rating in a report on Tuesday, August 29th. Finally, Royal Bank Of Canada initiated coverage on Cardinal Health in a report on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 target price for the company. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the stock. Cardinal Health presently has a consensus rating of “Hold” and a consensus price target of $74.81.

WARNING: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/18/cardinal-health-inc-cah-shares-bought-by-quantbot-technologies-lp.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.